Director Carol Gallagher resigns from Certara board effective April 5, 2022

Certara, Inc.

Dr. Carol Gallagher resigned for personal reasons, effective April 5, 2022.
Resignation is not due to any disagreement with Certara's operations, policies, or practices.
Board size reduced from ten to nine directors.
Gallagher had served as Chair of the Compensation Committee and member of the Nominating and Corporate Governance Committee.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Carol Gallagher

Director

CERT · Certara, Inc.

Effective: 2022-04-05
Filed: April 7, 2022, 7:59 PM ET

On April 5, 2022, Dr. Carol Gallagher, a member of the Board of Directors of Certara, Inc. (the “Company”), Chair of the Compensation Committee, and member of the Nominating and Corporate Governance Committee notified the Company of her intention to resign as a director of the Company for personal reasons, effective April 5, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Carol Gallagher resigned as Director at Certara, Inc..

Action: resigned
Role: Director

Exact text from the filing

On April 5, 2022, Dr. Carol Gallagher, a member of the Board of Directors of Certara, Inc. (the “Company”), Chair of the Compensation Committee, and member of the Nominating and Corporate Governance Committee notified the Company of her intention to resign as a director of the Company for personal reasons, effective April 5, 2022.

View on SEC.gov

Certara, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-22-005137

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.